Genes in panel

Genetic Epilepsy

Gene: DBT

Green List (high evidence)

DBT (dihydrolipoamide branched chain transacylase E2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000137992
EnsemblGeneIds (GRCh37): ENSG00000137992
OMIM: 248610, ClinGen, DECIPHER
DBT is in 22 panels

1 review

Teresa Zhao (Victorian Clinical Genetics Services)

Green List (high evidence)

well reported gene causing Maple syrup urine disease, type II (MIM#248600)
Created: 24 Jul 2020, 6:19 p.m. | Last Modified: 24 Jul 2020, 6:19 p.m.
Panel Version: 0.3507

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Maple syrup urine disease, type II (MIM#248600)

Publications

History Filter Activity

26 Sep 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: dbt has been classified as Green List (High Evidence).

26 Sep 2022, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: DBT was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

26 Sep 2022, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: DBT were changed from to Maple syrup urine disease, type II (MIM#248600)

26 Sep 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag treatable tag was added to gene: DBT.

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: DBT was added gene: DBT was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Australian Genomics Health Alliance Epilepsy Flagship,Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: DBT was set to Unknown